Search
Searching Content by Agnieszka Deeg from CMS Cameron McKenna Nabarro Olswang LLP ordered by Published Date Descending.
Links to Result pages
 
1  
 
Title
Country
Organisation
Author
Date
1
Pharmaceutical Inspectorate to Rule on Direct Drug Sales from Outside Poland
The Chief Pharmaceutical Inspector is entitled to supervise all pharmaceutical trade in Poland, including trade by companies based outside Poland, according to the Voivodship Administrative Court in Warsaw.
Poland
17 Nov 2010
2
Proposed Changes to Pharmaceutical Advertising
Significant proposed changes to pharmaceutical advertising are included in the ‘health pack’ currently being considered in Parliament.
Poland
1 Nov 2010
3
Extended Data Exclusivity Period for Pharmaceuticals
The data exclusivity period applicable to pharmaceuticals for human use is to be extended by the introduction of an 8+2+1 rule to replace the current 6-year exclusivity period.
Poland
27 Oct 2010
4
New System For Pricing and Reimbursement Of Pharmaceuticals and Medical Devices
The procedures for setting prices and applying for reimbursement of pharmaceuticals and medical devices is to be fundamentally changed.
Poland
15 Oct 2010
5
New Rules For Dietary Supplements
From 4 June 2010, new rules apply to the composition and labeling of dietary supplements.
Poland
10 Jun 2010
6
New 5-Year Retention Period For Clinical Trial Documents
From 22 March 2010, the period for which sponsors must keep basic documentation of a clinical trial will be extended from two to five years.
Poland
15 Mar 2010
7
Interim Period For Borderline Products Expires
The interim period for borderline products will expire on 31 December 2009 after attempts to extend it failed.
Poland
4 Jan 2010
8
Amendment To The Food Safety Act
Foodstuffs such as dietary supplements may be subject to amended procedure where there are concerns whether they meet the criteria for medicinal products.
Poland
4 Jan 2010
Links to Result pages
 
1